These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 19523152)
21. Clinical relevance of preformed C4d-fixing and non-C4d-fixing HLA single antigen reactivity in renal allograft recipients. Wahrmann M; Bartel G; Exner M; Regele H; Körmöczi GF; Fischer GF; Böhmig GA Transpl Int; 2009 Oct; 22(10):982-9. PubMed ID: 19619171 [TBL] [Abstract][Full Text] [Related]
22. Influence of recipient and donor IL-1alpha, IL-4, and TNFalpha genotypes on the incidence of acute renal allograft rejection. Lee H; Clark B; Gooi HC; Stoves J; Newstead CG J Clin Pathol; 2004 Jan; 57(1):101-3. PubMed ID: 14693849 [TBL] [Abstract][Full Text] [Related]
23. How much donor human leukocyte antigen-specific antibody is too much for a renal transplant? Vaughan R; Shaw O Transplantation; 2008 Apr; 85(8):1081-2. PubMed ID: 18431224 [No Abstract] [Full Text] [Related]
24. Impact of chemokine receptor CCR2 and CCR5 gene polymorphism on allograft outcome in North Indian renal transplant recipients. Singh R; Kapoor R; Srivastava A; Mittal RD Scand J Immunol; 2009 Jan; 69(1):51-6. PubMed ID: 19037908 [TBL] [Abstract][Full Text] [Related]
25. Pretransplant screening for donor-specific antibodies and graft loss. Focosi D; Boggi U Transplantation; 2011 Aug; 92(4):e15; author reply e15-6. PubMed ID: 21814123 [No Abstract] [Full Text] [Related]
27. Development of non-donor-specific HLA antibodies after kidney transplantation: frequency and clinical implications. Briggs D; Zehnder D; Higgins RM Contrib Nephrol; 2009; 162():107-16. PubMed ID: 19001818 [TBL] [Abstract][Full Text] [Related]
28. Peripheral blood immune response-related gene analysis for evaluating the potential risk of chronic antibody-mediated rejection. Yamamoto T; Iwasaki K; Murotani K; Takeda A; Futamura K; Okada M; Tsujita M; Hiramitsu T; Goto N; Narumi S; Watarai Y; Morozumi K; Uchida K; Kobayashi T Hum Immunol; 2018 Jun; 79(6):432-438. PubMed ID: 29614336 [TBL] [Abstract][Full Text] [Related]
29. The role of the class II transactivator (CIITA) in MHC class I and II regulation and graft rejection in kidney. Sims TN; Afrouzian M; Urmson J; Zhu LF; Halloran PF Am J Transplant; 2001 Sep; 1(3):211-21. PubMed ID: 12102254 [TBL] [Abstract][Full Text] [Related]
30. Impact of polymorphisms of TLR4/CD14 and TLR3 on acute rejection in kidney transplantation. Hwang YH; Ro H; Choi I; Kim H; Oh KH; Hwang JI; Park MH; Kim S; Yang J; Ahn C Transplantation; 2009 Sep; 88(5):699-705. PubMed ID: 19741468 [TBL] [Abstract][Full Text] [Related]
31. Antibodies against the donor antigen glutathione S-transferase T1 after renal transplantation. Aguilera I; Wichmann I; Gentil MA; Gonzalez-Escribano F; Nuñez-Roldan A Transplant Proc; 2005 Apr; 37(3):1457-8. PubMed ID: 15866637 [TBL] [Abstract][Full Text] [Related]
32. HLA-specific antibodies developed in the first year posttransplant are predictive of chronic rejection and renal graft loss. Lee PC; Zhu L; Terasaki PI; Everly MJ Transplantation; 2009 Aug; 88(4):568-74. PubMed ID: 19696641 [TBL] [Abstract][Full Text] [Related]
33. Renal graft loss in recipients with at least one year of function and donor specific antibody (DSA). Cicciarelli J; Shah T; Koss M; Houston K; Narahghi R Clin Transpl; 2006; ():539-40. PubMed ID: 18365421 [No Abstract] [Full Text] [Related]
34. Intact HLA not beta2m-free heavy chain-specific HLA class I antibodies are predictive of graft failure. Cai J; Terasaki PI; Anderson N; Lachmann N; Schönemann C Transplantation; 2009 Jul; 88(2):226-30. PubMed ID: 19623018 [TBL] [Abstract][Full Text] [Related]
35. Postoperative production of anti-donor antibody and early graft loss due to vascular rejection in renal transplantation. Abe M; Sannomiya A; Koike T; Sato S; Sageshima J; Murakami T; Uchida Y; Nakajima I; Fuchinoue S; Teraoka S; Yamaguchi Y; Toma H; Agishi T Transplant Proc; 1998 Nov; 30(7):2963. PubMed ID: 9838307 [No Abstract] [Full Text] [Related]
36. Donor genetic variants in interleukin-6 and interleukin-6 receptor associate with biopsy-proven rejection following kidney transplantation. Poppelaars F; Gaya da Costa M; Eskandari SK; Damman J; Seelen MA Sci Rep; 2021 Aug; 11(1):16483. PubMed ID: 34389747 [TBL] [Abstract][Full Text] [Related]
37. MICA compatibility and immunization in third kidney transplantations. Gautier AC; Devys A; Cheneau ML; Simon PH; Martin C; Allard S; Hourmant M; Bignon JD Transplant Proc; 2009 Mar; 41(2):663-5. PubMed ID: 19328950 [TBL] [Abstract][Full Text] [Related]
38. Four short projects about antibodies, soluble CD30, and organ transplant rejection. Stastny P; Spells K; Rogers J; Zou Y; Lavingia B Clin Transpl; 2006; ():337-47. PubMed ID: 18365388 [No Abstract] [Full Text] [Related]
39. Molecular characterization of chicken class II transactivator gene. Nikbakht Brujeni G; Khosravi M Immunogenetics; 2015 Jan; 67(1):39-49. PubMed ID: 25339383 [TBL] [Abstract][Full Text] [Related]
40. The PTPN22 C1858T (R620W) functional polymorphism in kidney transplantation. Sfar I; Gorgi Y; Aouadi H; Maklouf M; Ben Romdhane T; Jendoubi-Ayed S; Bardi R; Abderrahim E; Ben Abdallah T; Ayed K Transplant Proc; 2009 Mar; 41(2):657-9. PubMed ID: 19328948 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]